Get the Stockscreener App
4.11
4.31%
0.17
Mannkind Corp stock is traded at $4.11, with a volume of 3.05M.
It is up +4.31% in the last 24 hours and up +4.58% over the past month.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
See More
Previous Close:
$3.94
Open:
$3.96
24h Volume:
3.05M
Relative Volume:
1.06
Market Cap:
$1.26B
Revenue:
$248.37M
Net Income/Loss:
$11.74M
P/E Ratio:
82.20
EPS:
0.05
Net Cash Flow:
$18.24M
1W Performance:
+10.19%
1M Performance:
+4.58%
6M Performance:
-28.65%
1Y Performance:
-22.89%
1-Day Range:
$3.9501
$4.12
1-Week Range:
$3.74
$4.12
52-Week Range:
$3.3812
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Name
Mannkind Corp
Sector
Industry
Phone
818-661-5000
Address
1 CASPER STREET, DANBURY, CA
Compare MNKD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
4.11 | 1.17B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Resumed | H.C. Wainwright | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Feb-10-25 | Initiated | Wedbush | Outperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-10-23 | Initiated | Wedbush | Outperform |
| May-14-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-24-19 | Initiated | Oppenheimer | Outperform |
| Oct-25-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-14-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
| Feb-28-18 | Downgrade | Maxim Group | Hold → Sell |
| Nov-01-17 | Downgrade | Maxim Group | Buy → Hold |
| Oct-10-17 | Initiated | H.C. Wainwright | Buy |
| Oct-06-17 | Reiterated | Maxim Group | Buy |
| Aug-11-17 | Initiated | Maxim Group | Buy |
| May-10-16 | Reiterated | Piper Jaffray | Underweight |
| May-10-16 | Reiterated | RBC Capital Mkts | Underperform |
| Jan-06-16 | Reiterated | Piper Jaffray | Underweight |
| Jan-06-16 | Reiterated | RBC Capital Mkts | Underperform |
| Nov-04-15 | Downgrade | RBC Capital Mkts | Outperform → Underperform |
| Sep-09-15 | Downgrade | Piper Jaffray | Neutral → Underweight |
| Aug-03-15 | Reiterated | RBC Capital Mkts | Outperform |
| May-11-15 | Downgrade | JP Morgan | Neutral → Underweight |
| May-11-15 | Reiterated | MLV & Co | Hold |
| Apr-16-15 | Reiterated | RBC Capital Mkts | Outperform |
View All
Mannkind Corp Stock (MNKD) Latest News
Is now a turning point for MannKind CorporationMarket Sentiment Summary & Fast Moving Stock Trade Plans - Newser
Regression analysis insights on MannKind Corporation performance2025 Institutional Moves & High Yield Stock Recommendations - Newser
Is MannKind Corporation stock reversal real or fakeGold Moves & Expert Approved Trade Ideas - Newser
Using fundamentals and technicals on MannKind CorporationQuarterly Earnings Report & Long Hold Capital Preservation Plans - Newser
Does MannKind Corporation fit your quant trading modelWeekly Profit Report & High Accuracy Swing Entry Alerts - Newser
MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline - Yahoo Finance
Applying big data sentiment scoring on MannKind CorporationMarket Activity Recap & Community Verified Watchlist Alerts - Newser
Can MannKind Corporation outperform in the next rally2025 Retail Activity & Weekly Hot Stock Watchlists - thegnnews.com
ISCG's Underlying Holdings Predict 18% Gain Potential - AInvest
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement - WebWire
MannKind Corporation (NASDAQ:MNKD) Q2 2025 Earnings Call Transcript - Insider Monkey
MannKind Corporation: A Post-Q2 2025 Deep Dive — Is This the Catalyst-Driven Turnaround Play Investors Have Been Waiting For? - AInvest
MannKind And Blackstone Announce Up To $500 Mln Strategic Financing Agreement - Nasdaq
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update - GlobeNewswire
MannKind shares tumble as revenue misses expectations By Investing.com - Investing.com South Africa
MannKind shares tumble as revenue misses expectations - Investing.com
Earnings call transcript: MannKind Q2 2025 results see mixed market reaction - Investing.com
MannKind (MNKD) Q2 Revenue Rises 6% - The Motley Fool
MannKind (MNKD) Secures $500 Million Strategic Financing from Bl - GuruFocus
MannKind Corp stock hits 52-week low at 3.5 USD By Investing.com - Investing.com Australia
MannKind Corp stock hits 52-week low at 3.5 USD - Investing.com India
MannKind Corp reports results for the quarter ended June 30Earnings Summary - TradingView
MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
MannKind Announces $500M Financing Agreement With Blackstone After Q2 Revenue Miss: Retail Believes Stock Is ‘Ridiculously Undervalued’ - Stocktwits
MannKind (MNKD) Reports Break-Even Earnings for Q2 - Yahoo Finance
MannKind secures up to $500 million strategic financing from Blackstone - Investing.com
MannKind Corporation Secures Up to $500 Million Strategic Financing Agreement with Blackstone - Quiver Quantitative
MannKind Corporation Reports Second Quarter 2025 Financial Results - TradingView
Wedbush Maintains a Buy on MannKind Corporation (MNKD) - Insider Monkey
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of MannKind Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2016MNKD - ACCESS Newswire
H.C. Wainwright Affirms MannKind Corp (MNKD)’s ‘Buy’ Rating Buoyed by Product Pipeline - Insider Monkey
MannKind Corporation Receives 'Buy' Rating from H.C. Wainwright Amid Strong Growth and Promising Product Pipeline - AInvest
Wedbush Remains Bullish on MannKind Corporation (MNKD) - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
10 Penny Stocks That Will Skyrocket - Insider Monkey
MannKind Corporation to Release Second Quarter 2025 Financial Results and Host Webcast on August 6, 2025 - Quiver Quantitative
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025 - GlobeNewswire
What makes MannKind Corporation stock price move sharplyMomentum Based Equity Trading Plans Reviewed - metal.it
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
AI Tools Suggest MannKind Corporation May Outperform This WeekChart Driven High Reward Trading Setup Presented - metal.it
Why is MannKind Corporation stock attracting strong analyst attentionFree Daily Trading Room Entry - Jammu Links News
How volatile is MannKind Corporation stock compared to the marketCapitalize on fast-moving stock opportunities - Jammu Links News
RBC Capital Lowered the PT on MannKind Corporation (MNKD), Kept a Buy Rating - Insider Monkey
How MannKind Corporation stock performs during market volatilityCapital Safe Smart Trades - metal.it
7 High Growth Penny Stocks That Are Profitable in 2025 - Insider Monkey
What drives MannKind Corporation stock priceFree Stock Selection - PrintWeekIndia
MannKind stock price target lowered to $8 at RBC Capital on model updates - Investing.com Canada
Mannkind Corp Stock (MNKD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mannkind Corp Stock (MNKD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thomson David | EVP Genl Counsel & Secretary |
Jul 16 '25 |
Sale |
3.94 |
7,466 |
29,416 |
841,719 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):